Skip to main content
. 2016 Mar 3;2(4):e69. doi: 10.1097/TXD.0000000000000579

TABLE 4.

Treatment-emergent adverse events in at least 10% of patients in either group (safety population)

graphic file with name txd-2-e69-g007.jpg